ZINFORO®: Simple twice-daily dosing1
No dosage adjustment is required for most elderly patients or those with concurrent comorbidities.1
Dosage in adults aged 18 years and older1
600 mg IV (over 5-60 minutes) q12h
Treatment duration
5 to 7 days for CAP
5 to 14 days for cSSTI
Dosage adjustments are required in patients with moderate to severe (CrCl ≥15 mL/min to ≤50 mL/min) renal impairment and ESRD, including in patients undergoing haemodialysis.1
Header | ||
---|---|---|
Header | Header | Header |
Content | Content | Content |
Content | Content | Content |
Content | Content | Content |
Content | Content | Content |
Content | Content | Content |
Content | Content | Content |
Content | Content | Content |
Content | Content | Content |
Reference:
Fifth-generation cephalosporin with broad coverage
Simple dosing with a flexible infusion time
Safety profile consistent with other cephalosporins
These pages are not intended for patients or for members of the general public. The web pages contain promotional content.
If you select 'No', you will be redirected to Pfizer.co.in
For more details on, Who is a Registered Medical Practitioner*, please visit
https://cdsco.gov.in/opencms/export/sites/CDSCO_WEB/Pdf-documents/acts_rules/2016DrugsandCosmeticsAct1940Rules1945.pdf , Page No. 39, Rule 2 part (ee), last accessed on 13th September 2019.
Address: The Capital, A Wing, 1802, 18th Floor, Plot No. C-70, 'G' Block, Bandra Kurla Complex, Bandra East, Mumbai - 400051.